Funding source in Global project
Year:

This study was supported by the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2019-I2M-5-011, 2022-I2M-C&T-B-099, 2023-I2M-C&T-B-121), the 1·3·5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (ZYJC21008), and the Key Research and Development Project of Ningxia Hui Autonomous Region (2021BEGO2036).

Check the details 2(25.00%)

corporate sponsorship/Seagen Inc.&Astellas Pharma US, Inc.

Check the details 1(12.50%)

HOYA Medical Singapore Pte. Ltd.

Check the details 1(12.50%)

Merck Serono Co., Ltd

Check the details 1(12.50%)

PharmaEssentia Corporation

Check the details 1(12.50%)

Scientific funding

Check the details 1(12.50%)

The author's own work

Check the details 1(12.50%)